Stericycle, Inc.
SRCL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | -1.7% | 2.2% | -1.1% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 37.7% | 37.9% | 38.4% | 39.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 2.9% | 5.7% | 2.7% | 5.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | -$0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -0.8% | 2.1% | -1% | -2.1% |
| EPS | -0.23 | 0.61 | -0.29 | -0.61 |
| % Growth | -137.7% | 310.3% | 52.5% | – |
| EPS Diluted | -0.23 | 0.61 | -0.29 | -0.61 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 11% | 15.3% | 14.9% | 16% |